Genedrive PLC

Public Limited Company · Manchester

ActiveUnited KingdomIncorporated 2007Public Limited Company

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No electronic account filings

No extracted electronic accounts are available in our records.

Registered details

06108621

Status: Active
Type: Public Limited Company
Incorporated: 2007-02-15
Jurisdiction: —
Registered office: THE INCUBATOR BUILDING, MANCHESTER, M13 9XX

Classification

1 SIC codes

33006

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

4 matched grants

The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) Programme [Extension]

Innovate UK · Investment Accelerator · 2025-04-01 – 2026-03-31 · with 6 other participants

£199,896

awarded

The University of Manchesterlead£295,409

Genedrive PLC£199,896

Apis Assay Technologies Ltd.£74,800

Manchester University NHS Foundation Trust£32,354

Chromition Limited£30,000

Emqn C.I.C.£25,000

Health Innovation Manchester£0

The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) Programme

Innovate UK · Collaborative R&D · 2023-04-01 – 2025-03-31 · with 6 other participants

£280,114

awarded

The University of Manchesterlead£1,090,980

Chromition Limited£334,354

Genedrive PLC£280,114

Emqn C.I.C.£182,252

Apis Assay Technologies Ltd.£166,059

Manchester University NHS Foundation Trust£118,606

Health Innovation Manchester, hosted by Manchester University NHS Foundation Trust£0

A novel pathogen capture sample preparation device for point of care TB diagnostics on the genedrive molecular diagnostics platform

Innovate UK · Collaborative R&D · 2018-06-01 – 2019-11-30 · with 1 other participant

£431,692

awarded

Genedrive Diagnostics Ltdlead£676,267

Genedrive PLC£431,692

Centrifuge-free plasma separation consumable for global point of care viral diagnosticsLead

Innovate UK · Collaborative R&D · 2017-12-01 – 2020-02-29 · with 2 other participants

£484,292

awarded

Genedrive PLClead£484,292

University of Dundee£97,322

Tayside NHS Health Board£17,000